EUVIMEDEUVIMED entdecken
Multizentrische Studie

Early Outcomes for Management of Atrioventricular Septal Defect—Tetralogy of Fallot in the Last Decade: A Congenital Heart Surgeons’ Society Study

Connor P Callahan, Madison B Argo iD, Brian W McCrindle, David J Barron iD, Anusha Jegatheeswaran, Osami Honjo, Anastasios C Polimenakos, Joseph W Turek, Robert J Dabal, James K Kirklin iD, William M DeCampli iD, Pirooz Eghtesady und 2 weitere

World Journal for Pediatric and Congenital Heart Surgery · 2025

DOI: 10.1177/21501351241293158 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift World Journal for Pediatric and Congenital Heart Surgery, 2025. Verfasst von Connor P Callahan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA. Hauptthemen laut MEDLINE: Tetralogy of Fallot, Cardiac Surgical Procedures. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We sought to determine the management and early outcomes of complete atrioventricular septal defect—tetralogy of Fallot (AVSD-TOF) for a contemporary multicenter cohort.

Methods

Of 739 participants in the Congenital Heart Surgeons' Society AVSD cohort (January 2012-May 2021), 40 had AVSD-TOF. We first compared survival differences for patients with AVSD-TOF versus those with isolated AVSD using propensity matching. Secondly, for patients with AVSD-TOF, we compared staged (n = 16) versus primary (n = 24) repair by assessing the following: patient characteristics, progression of atrioventricular valve (AVV) regurgitation, and time-related reoperation and survival.

Results

Five-year survival was similar between matched AVSD-TOF and isolated AVSD groups (80% vs 81%, P = .9). Compared with primary repair patients, staged patients had smaller pulmonary valve annulus Z-score measured at first presentation (−2.2 vs −2.9, P = .006). All staged patients (12 Blalock-Thomas-Taussig shunts, 3 right-ventricular-outflow-tract stents, 1 ductal stent) survived to complete repair. Freedom from AVSD-related reoperation five years post-AVSD-TOF repair was 57% after staged versus 90% after primary repair ( P < .05) and left AVV reoperations were the most frequent reintervention. Survival five years after AVSD-TOF repair was 80% (63% after staged vs 90% after primary repair; P = .08).

Conclusions

Patients undergoing AVSD-TOF repair have similar survival compared with matched isolated AVSD patients. Although approximately half of AVSD-TOF patients had initial palliation and all survived to complete repair, staged repair patients had lower survival and a higher reintervention rate compared with primary repair patients. The decision to pursue staged versus primary repair for future babies with AVSD-TOF remains challenging and should be chosen based on individual circumstances.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tetralogy of FallotCardiac Surgical ProceduresHumansFemaleMaleInfantReoperationTreatment OutcomeRetrospective StudiesChild, PreschoolSurvival RateSocieties, MedicalInfant, NewbornPropensity Score

Stichwörter der Autor:innen

common atrioventricular canal defectcongenital heart surgerypropensity matchingpulmonary valve

Autor:innen und Institutionen

  • Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
  • Department of Surgery, University of Wisconsin Hospital and Clinics, Madison, WI, USA.
  • Division of Cardiovascular Surgery, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Pediatric Cardiology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Department of Cardiothoracic Surgery, Great Ormond Street Hospital for Children, London, UK.
  • Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK.

ORCID-Profile: Madison B Argo, David J Barron, James K Kirklin, William M DeCampli

Zitieren

APA

Callahan, C. P., Argo, M. B., McCrindle, B. W., Barron, D. J., Jegatheeswaran, A., Honjo, O., Polimenakos, A. C., Turek, J. W., Dabal, R. J., Kirklin, J. K., DeCampli, W. M., Eghtesady, P., Overman, D. M., & Congenital Heart Surgeons’ Society AVSD-TOF Working Group (2025). Early Outcomes for Management of Atrioventricular Septal Defect—Tetralogy of Fallot in the Last Decade: A Congenital Heart Surgeons’ Society Study. World Journal for Pediatric and Congenital Heart Surgery. https://doi.org/10.1177/21501351241293158

Vancouver

Callahan CP, Argo MB, McCrindle BW, Barron DJ, Jegatheeswaran A, Honjo O, et al. Early Outcomes for Management of Atrioventricular Septal Defect—Tetralogy of Fallot in the Last Decade: A Congenital Heart Surgeons’ Society Study. World Journal for Pediatric and Congenital Heart Surgery. 2025. doi:10.1177/21501351241293158

BibTeX
@article{Callahan2025,
  author = {Callahan, Connor P and Argo, Madison B and McCrindle, Brian W and Barron, David J and Jegatheeswaran, Anusha and Honjo, Osami and Polimenakos, Anastasios C and Turek, Joseph W and Dabal, Robert J and Kirklin, James K and DeCampli, William M and Eghtesady, Pirooz and Overman, David M and Congenital Heart Surgeons’ Society AVSD-TOF Working Group, Congenital Heart Surgeons’ Society AVSD-TOF Working Group},
  title = {Early Outcomes for Management of Atrioventricular Septal Defect—Tetralogy of Fallot in the Last Decade: A Congenital Heart Surgeons’ Society Study},
  journal = {World Journal for Pediatric and Congenital Heart Surgery},
  year = {2025},
  doi = {10.1177/21501351241293158}
}
Kostenlos starten →